NaREP2Se6 (RE = Y, Sm, Gd-Dy): Quaternary Rare-Earth Selenophosphates with Unique 3D {[REP2Se6]-}∞ Framework Built by RESe8 and P2Se6 Motifs and Multiple Properties.

Rare-earth (RE) chalcophosphates have been widely studied because of their abundant structures. Here, five new RE selenophosphates, NaREP2Se6 (RE = Y, Sm, Gd-Dy), were synthesized by a facile RE oxide-boron-selenium solid-state route. They crystallize in the triclinic P1̅ space group, featuring three-dimensional (3D) structures constructed by RESe8 and P2Se6 motifs, different from common 2D RE chalcophosphates A-RE-P2-Q6 (A = alkali metal; Q = S, Se) system. Their structural chemistry and relationship with related phases are analyzed. Both the size of A and the coordination geometry of RE have important influences on the system's structures. Their optical band gaps are tunable from 1.79 to 2.50 eV, and they exhibit diverse magnetic behaviors, including Van-Vleck-type paramagnetism, antiferromagnetism, and ferromagnetism. Their photocurrent responses and thermal stabilities are analyzed as well. Calculation results suggest that the RESe8 and P2Se6 units make a great contribution to the optical properties. This work enriches the chemistry and multifunctional properties of RE chalcophosphates.

KREP2 Se6 (RE = Sm, Gd, Tb): The First Rare-Earth Selenophosphates with Remarkable Nonlinear Optical Activities Realized by Synergistic Effect of RE- and P-Based Motifs.

Rare-earth (RE) chalcogenides have been extensively studied as infrared nonlinear optical (NLO) materials because of their nice integrated performances; however, very few RE chalcophosphates are involved for this topic. Here, three quaternary RE selenophosphates, KSmP2 Se6 (1), KGdP2 Se6 (2), and KTbP2 Se6 (3), are profoundly studied for their NLO potentials. Their noncentrosymmetric P21 structures feature RESe8-bicapped trigonal prisms and ethane-like [P2 Se6 ]4 - dimers built {[REP2 Se6 ]-}∞ layers. As the first studied NLO-active RE selenophosphates, 1-3 exhibit second harmonic generation (SHG)responses ≈0.34-1.08 × AgGaS2 at 2.10 µm and laser-induced damage thresholds (LIDTs) ≈1.43-4.33 × AgGaS2 , and they all show phase-matchable behaviors, indicating their wonderful balanced NLO properties. Theoretical calculations demonstrate that the synergistic effect between RESe8 and P2 Se6 units makes the major contribution to the SHG responses.

[Clinical phenotype genotype correlation in children with hemoglobin H disease in Zhuhai area of China].

OBJECTIVE: Alpha-thalassemia is one of the most common monogene disorders in the world. Most frequently, it is caused by deletions of alpha-globin gene (-alpha or --), and less commonly resulted from the non-deletional mutation (alpha(T)alpha). Hemoglobin H (HbH) disease is the most severe type among survivors of alpha-thalassemia. The clinical presentation of children with the disease was highly heterogeneous. The aim of this study was to investigate the effect of alpha-globin genotypes in the children with HbH disease on predicting the phenotypic severity and to define the factors involved in the disease progress. METHODS: Forty-three children with the disease in Zhuhai area of Guangdong, China were examined by using established techniques to detect genotypes of alpha-globin and to determine all hematological parameters. All detailed clinical data of the cases were recorded. Then clinical and hematological findings, and the correlation with genotypes were evaluated. RESULTS: Six alpha-thalassemia mutations were detected and interacted to produce 5 HbH disease genotypes. Of these genotypes, -alpha(3.7)/--(SEA)(60%), -alpha(4.2)/--(SEA) (19%) and alpha(CS)alpha/--(SEA) (12%) HbH diseases were prevalent in the area. Compared with -alpha(3.7)/--(SEA) HbH disease, significantly lower red blood cell (RBC) count, hemoglobin (Hb), mean corpuscular hemoglobin (MCHC) and HbA(2) (P < 0.05, 0.01, 0.01 and 0.01, respectively), and significantly higher mean corpuscular hemoglobin volume (MCV) and HbH levels (both P < 0.01), and more severe clinical phenotypes were found in the HbH disease with alpha(T)alpha/--(SEA) genotype. While the differences were much more significant when compared with -alpha(3.7)/--(SEA) then compared with -alpha(4.2)/--(SEA) not only in the hematological parameters, but also in the severity of clinical phenotypes. In addition, HbH levels showed anegatively correlation with the RBC count (r = -0.39, P < 0.01). CONCLUSION: The phenotypes of HbH disease may be mainly related to the underlying genotypes. The children with alpha(T)alpha/--(SEA) genotype presented with more severe hematological and clinical phenotypes followed by the -alpha(4.2)/--(SEA) and then -alpha(3.7)/--(SEA) genotypes. But phenotypic severity was not simply related to the degree of alpha-globin deficiency. HbH levels were found to exacerbate anemia. These data might provide comprehensive and very valuable and basic information for the management of HbH disease, genetic counseling and prenatal diagnosis.